OOIR: Observatory of International Research

Papers

(The H4-Index of Prostate International is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Does androgenic alopecia aggravate the risk of prostate cancer? Evidence from Mendelian randomization	61
Oncological outcomes after radical prostatectomy of localized prostate cancer: stratified by magnetic resonance imaging and risk classification	40
Integrated Clinical and Magnetic Resonance Imaging-Based Prediction Model for Pelvic Lymph Node Metastasis in Prostate Cancer	28
Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer	28
The association between behavioral habits and physical health status in prostate cancer patients: a large US national health-related survey	23
Association between pelvic lymph node dissection and survival among patients with prostate cancer treated with radical prostatectomy	22
Treatment outcomes with radium-223 in patients with metastatic castration-resistant prostate cancer with bone metastasis in real-world practice: a multiinstitutional study	20
Therapeutic potentials of curcumin in prostate cancer: a comprehensive review of pathways and clinical prospects	20
Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign	19
Association between preradiation therapy prostate-specific antigen levels and radiation therapy failure after prostatectomy: a propensity score matched analysis	19
Holmium laser enucleation of the prostate as a treatment option for patients with concurrent outlet obstruction and bladder diverticulum	16
Holmium laser enucleation of the prostate versus transurethral resection of the prostate for benign prostatic hyperplasia: evidence from a Korean retrospective analysis using the Common Data Model	16
Safety and efficacy of extracorporeal shockwave therapy on chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled study	15
Efficacy and safety of low-dose red ginseng oil(RXGIN) in men with moderate lower urinary tract symptoms: a randomized, double-blind, placebo-controlled trial	15
Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre	14
The accuracy of transperineal template-guided mapping biopsy in patients with negative magnetic resonance imaging	14